Practice Changing Potential of TAILORx: A Retrospective Review of the National Cancer Data Base from 2010 to 2015
2019
Background
Uncertainty regarding chemotherapy benefit among breast cancer patients with intermediate Oncotype Dx® recurrence scores (RS; 11–25) led to the TAILORx study. We evaluated chemotherapy use in patients with intermediate RS to determine practice change potential based on the TAILORx results.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
36
References
4
Citations
NaN
KQI